Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518183 | SCV000616231 | pathogenic | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | This variant has been identified in multiple unrelated individuals with clinical features associated with this gene, and segregates with disease in at least one family. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant occurs as the most likely explanation for disease in a significant number of internal cases, suggesting this variant is associated with disease. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 16135773) |
Fulgent Genetics, |
RCV002251317 | SCV001752771 | pathogenic | Familial juvenile hyperuricemic nephropathy type 1 | 2022-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000518183 | SCV003787051 | pathogenic | not provided | 2024-10-03 | criteria provided, single submitter | clinical testing | This variant, c.529_555del, results in the deletion of 9 amino acid(s) of the UMOD protein (p.His177_Arg185del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with familial juvenile hyperuricaemic nephropathy (PMID: 12471200). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12254). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV002251317 | SCV000033287 | pathogenic | Familial juvenile hyperuricemic nephropathy type 1 | 2002-12-01 | no assertion criteria provided | literature only | |
Gene |
RCV002251317 | SCV001999872 | not provided | Familial juvenile hyperuricemic nephropathy type 1 | no assertion provided | literature only | Common pathogenic variant | |
Prevention |
RCV004739301 | SCV005345123 | pathogenic | UMOD-related disorder | 2024-08-16 | no assertion criteria provided | clinical testing | The UMOD c.529_555del27 variant is predicted to result in an in-frame deletion (p.His177_Arg185del). In a linkage mapping and sequencing study, this variant has been reported to completely segregate with disease in a large multigenerational family affected by familial juvenile hyperuricaemic nephropathy (Family 1 in Hart et al. 2002. PubMed ID: 12471200). In addition, this variant has also been reported in patients with UMOD-related diseases (Table S3 of Bleyer et al. 2022. PubMed ID: 35325889; Table S1 of Olinger et al. 2020. PubMed ID: 32450155; Wilson et al. 2020. PubMed ID: 35372954). In the ClinVar database, this variant has been interpreted as pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/12254/). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. |